Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Morel

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Blood Advances|November 9, 2020
Processing methods and storage duration impact extracellular vesicle counts in red blood cell unitsClementine Gamonet, Maxime Desmarets, Guillaume Mourey, et al.
Frontiers in Immunology|October 24, 2022
Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technologyFabrice Cognasse, Hind Hamzeh-Cognasse, Anne-Claire Duchez, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|January 10, 2018
A new approach for diagnosing chronic myelomonocytic leukemia using structural parameters of Sysmex XN<sup>TM</sup> analyzers in routine laboratory practiceFrançoise Schillinger, Elise Sourdeau, Marouane Boubaya, et al.
Leukemia|February 2, 2022
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysisThomas Hueso, Anne-Sophie Godron, Emilie Lanoy, et al.
Ebiomedicine|December 19, 2022
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort studyFabrice Cognasse, Hind Hamzeh-Cognasse, Mickael Rosa, et al.
BMJ Medicine|November 3, 2023
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trialKarine Lacombe, Thomas Hueso, Raphael Porcher, et al.
Vox Sanguinis|November 27, 2020
Vox Sanguinis International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: SummaryMindy Goldman, Mary Townsend, Karin Magnussen, et al.
Vox Sanguinis|March 23, 2021
International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: ResponsesMindy Goldman, Mary Townsend, Karin Magnussen, et al.
Science Translational Medicine|August 21, 2020
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populationsLudivine Grzelak, Sarah Temmam, Cyril Planchais, et al.
Vox Sanguinis|May 20, 2021
International Forum on the Collection and Use of COVID-19 Convalescent Plasma: ResponsesArwa Z Al-Riyami, Thierry Burnouf, Mark Yazer, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Blood Advances|November 9, 2020
Processing methods and storage duration impact extracellular vesicle counts in red blood cell unitsClementine Gamonet, Maxime Desmarets, Guillaume Mourey, et al.
Frontiers in Immunology|October 24, 2022
Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technologyFabrice Cognasse, Hind Hamzeh-Cognasse, Anne-Claire Duchez, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|January 10, 2018
A new approach for diagnosing chronic myelomonocytic leukemia using structural parameters of Sysmex XN<sup>TM</sup> analyzers in routine laboratory practiceFrançoise Schillinger, Elise Sourdeau, Marouane Boubaya, et al.
Leukemia|February 2, 2022
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysisThomas Hueso, Anne-Sophie Godron, Emilie Lanoy, et al.
Ebiomedicine|December 19, 2022
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort studyFabrice Cognasse, Hind Hamzeh-Cognasse, Mickael Rosa, et al.
BMJ Medicine|November 3, 2023
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trialKarine Lacombe, Thomas Hueso, Raphael Porcher, et al.
Vox Sanguinis|November 27, 2020
Vox Sanguinis International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: SummaryMindy Goldman, Mary Townsend, Karin Magnussen, et al.
Vox Sanguinis|March 23, 2021
International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: ResponsesMindy Goldman, Mary Townsend, Karin Magnussen, et al.
Science Translational Medicine|August 21, 2020
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populationsLudivine Grzelak, Sarah Temmam, Cyril Planchais, et al.
Vox Sanguinis|May 20, 2021
International Forum on the Collection and Use of COVID-19 Convalescent Plasma: ResponsesArwa Z Al-Riyami, Thierry Burnouf, Mark Yazer, et al.
Pageof 7